DF 60th anniversary
Creating Disease Severity and Quality-of-Life Scoring Systems for Blistering Diseases
Comparing the efficacy of existing therapies between clinical trials, as well as evaluating new treatments, requires an accurate and reliable assessment of the clinical nature of a disease. Yet the first comprehensive analysis of the interventions used to treat pemphigus, a range of autoimmune blistering diseases (AIBD), was inconclusive due to incomplete information, including absence…
The DF Turned 60 Years Young This Year and Will Continue to Revolutionize Dermatology
I find great joy in being part of something larger than myself and watching it grow. It’s much like watching a child mature and thrive on their own. As a long-term supporter, volunteer and Board member, it’s been incredibly exciting to see a small group of dedicated dermatologists work together to further our specialty and…
Where Scientific Innovation, Discovery and Clinical Dermatology Converge
Michael Rosenblum, MD, PhD, was a 20-year-old undergraduate at the University of British Columbia when his mother became ill with breast cancer. At the time, physician-scientists were just beginning to explore how the immune system could be directed to target cancer cells. At the forefront was Dr. Steven Rosenberg, who had written a book that…